Conditions that can develop from hormonal imbalance, and will respond favourably to Naturone Progesterone Therapy
Auto-immune disease – Lupus
Blood sugar; low - (hypoglycemia) and high (hyperglycemia)
Cancer of hormonally sensitive tissue
Cold hands and feet
Fertility and other female problems
Hair loss & excessive facial hair in women
Miscarriages and infertility
Post Natal Depression
HRT EXPOSED: Reports from Medical Research
USA JAMA Reports - Study Gives HRT The Thumbs Down. July 2002
Major studies are weighing in giving HRT the thumbs down. The consensus amongst the more informed and enlightened of researchers and clinicians is that the only real benefit of HRT is for short term relief of hot flashes (which is what it was originally approved for). There is little doubt that the widespread trend to use HRT for a range of therapeutic benefits ie heart disease, prevention of fractures, Alzheimer's Disease etc have all but now faded into the mists (myths) of junk science. Millions of women have unwittingly participated in this massive experiment. Once again the rush for profits without substantial, proven research has jeopardized the health and, no doubt, the lives of women around the world.
If hot flashes are the problem there are many safe, effective ways to resolve them. I still question the use of HRT which is made of two known carcinogens. Use of such options as natural progesterone cream, Maca, Vitamin E and C is preferable. Also, liver support herbs such as milk thistle and dandelion are also helpful. In addition, reduce or cut out the consumption of sugar, caffeine, alcohol, deep fried foods, refined carbohydrates and spicy food... major culprits to cause hot flashes. Needless to say, reducing stress levels, getting adequate rest and hydrating the body with good quality water are essential.
The following study was released on July 2, 2002 in the Journal of the American Medical Association.
Noncardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II)
http://www.npr.org/ramfiles/atc/20020702.atc.07.ram (Real Audio Player of National Public Radio story)
HRT 'doubles breast cancer risk'
Taking certain types of hormone replacement therapy (HRT) can double the risk of developing breast cancer, says a study of more than a million women.
The largest ever study into the link between HRT and breast cancer was conducted by scientists at Cancer Research UK's Epidemiology Unit in Oxford. This data, published in The Lancet, covered a million women who went for mammograms between 1996 and 2001.
About 1.5million women in the UK take HRT, with half taking the combined version. The research suggests the single pill moderately increases the risk of breast cancer, but the combined pill doubles the risk. In fact, this study is the first to report that HRT increases the risk of dying from breast cancer, by 22%.
It estimates HRT, taken by women to relieve the unpleasant symptoms of menopause, may have been responsible for an extra 20,000 cases of breast cancer in Britain in the last decade. It says that the combined HRT is responsible for 15,000 of those cases.
Current figures indicate that about 20 women in every 1,000 will develop breast cancer. But the study found for every 1,000 women who use HRT for 10 years from the age of 50, there will be an additional 19 cases of cancer in those using the combined estrogen and progestogen version (almost 100%) and an extra five in those using estrogen-only HRT (25%).
Women also have to bear in mind that estrogen-only HRT carries an increased risk of uterine cancer.
Women's risk of developing breast cancer decreases when she stops using HRT and is back to normal levels after five years, claims the research.
The Committee on the Safety of Medicines has reviewed the data and written to all health professionals. They stressed short-term HRT use is still beneficial, but those taking it for more than a year should heed the risks and discuss them with their GP.
Since hearing of the link with breast cancer, hundreds of women have contacted the helpline NHS Direct
If women choose to take HRT, they should be screened for breast cancer every year as a matter of course.
Using tibolone, a steroid treatment, also increased a woman's cancer risk.
Professor Valerie Beral, who led the research, said: "Since our results show a substantially greater increase in breast cancer with combined HRT, women need to weigh the increased risk of breast cancer caused by the addition of progestogen against the lowered risk of uterine cancer."
Next Page: Medical Reports